Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
2.930
+0.030 (1.03%)
Nov 21, 2024, 4:00 PM EST - Market closed
Zura Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
| Net Income | -47.25 | -60.36 | -28.08 | -46.91 |
| Asset Writedown & Restructuring Costs | - | 27.38 | 23.88 | - |
| Stock-Based Compensation | 16.38 | 9.66 | 0.36 | - |
| Other Operating Activities | 4.23 | 3.15 | -1.34 | 45 |
| Change in Accounts Payable | 5.36 | 5.94 | 4.09 | 0.23 |
| Change in Other Net Operating Assets | -0.02 | -0.83 | -0.23 | - |
| Operating Cash Flow | -21.31 | -15.05 | -1.31 | -1.68 |
| Sale (Purchase) of Intangibles | -5 | -8 | -13.09 | -30 |
| Investing Cash Flow | -5.03 | -8 | -13.09 | -30 |
| Total Debt Issued | - | - | 8.29 | - |
| Short-Term Debt Repaid | - | -10 | - | - |
| Total Debt Repaid | - | -10 | - | - |
| Net Debt Issued (Repaid) | - | -10 | 8.29 | - |
| Issuance of Common Stock | 68.16 | 120.61 | - | - |
| Other Financing Activities | 42.54 | 10.69 | -3.09 | - |
| Financing Cash Flow | 110.7 | 121.29 | 16.11 | 60 |
| Net Cash Flow | 84.36 | 98.24 | 1.71 | 28.32 |
| Free Cash Flow | -21.34 | -15.05 | -1.31 | -1.68 |
| Free Cash Flow Per Share | -0.33 | -0.46 | -5.75 | - |
| Levered Free Cash Flow | -18.87 | -25.08 | - | - |
| Unlevered Free Cash Flow | -18.87 | -25.08 | - | - |
| Change in Net Working Capital | -1.21 | -12.41 | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.